We have expertise in a variety of methods that can help developers when they are at an early stage in the development of their diagnostic. This work supports the development of the test by highlighting any improvements that could be made. This will ensure that the new test will be fit for purpose in the healthcare system. Our early stage evidence work also optimises the study design for future clinical studies. It helps to identify the most appropriate patient population, setting and clinical outcomes that should be examined.
Our work at this stage includes rapidly and critically appraising the evidence that a developer currently has on their diagnostic. This will highlight any gaps in the evidence and help the developer to produce an evidence generation strategy.
Read our rapid reviews published during the COVID-19 pandemic.
Look at the other work packages we offer at an early stage by clicking on the sections below.
We have expertise in finding the unmet needs in a disease area and shaping the design of new diagnostics to tackle these challenges.
Through engaging with our wide networks we can overcome barriers that might prevent the new diagnostic from being widely used.
We can identify current diagnosis methods that are needed as a benchmark when measuring the accuracy of new diagnostics.
Through our expertise in systematic reviews, developers can examine what competing technologies are available on the market.
Our expertise in care pathway analysis identifies scenarios where a new diagnostic could have the best benefit on patient care.
We can perform early economic modelling to help focus future product and evidence development and inform pricing strategies.